Skip to main content
logo
PRISM BioLab Co.,LTD (TYO:206A)
Japan flag Japan · Delayed Price · Currency is JPY
160.00
-3.00 (-1.84%)
Aug 6, 2026, 1:32 PM JST

PRISM BioLab Co.,LTD Financials Overview

Millions JPY. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
Revenue
711.65677.33305.62112.93554
Revenue Growth
74.08%121.63%170.64%-79.62%-
Gross Profit
299.29269.76160.5480.31535
Operating Income
-898.85-774.45-782.39-496.8767
Net Income
-962.31-833.7-1,050-526.9172
Earnings Per Share
-26.13-22.82-33.53-19.092.63
EPS Growth
-----

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023
Period EndingSep '25 Sep '24 Sep '23
Japan
11069.6368.04
United States of America
523.5219.211.78
Switzerland
43.8316.7912.06
Total
677.33305.62112.93

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Cash (Debt)
2,4542,9164,3921,1341,687
Net Cash Growth
-34.33%-33.62%287.32%-32.78%-
Net Cash Per Share
66.6579.81140.3041.0861.68
Cash & Investments
2,4542,9164,3921,1341,687

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
Operating Cash Flow
-1,234-1,468150.14-513.81-
Capital Expenditures
-78.66-64.7-205.79-34.59-
Free Cash Flow
-1,313-1,533-55.64-548.4-
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
Gross Margin
42.06%39.83%52.53%71.11%96.57%
Operating Margin
-126.30%-114.34%-256.00%-439.99%12.09%
Pretax Margin
-134.91%-122.73%-342.98%-465.53%13.18%
Profit Margin
-135.22%-123.09%-343.41%-466.60%13.00%
FCF Margin
-184.43%-226.34%-18.21%-485.63%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22
PS Ratio
8.479.1048.24--